WHO Steps into the Ring: First-Ever Guidelines Released for GLP-1 Drugs in Obesity Treatment

Eli Lilly Slashes Zepbound Prices Amid Political Pressure and Trump's Claims

The Weight of Success: Unpacking Novo Nordisk’s Stranglehold on the GLP-1 Market

The Unseen Benefit? How Weight-Loss Drugs Might Just Be Fighting Cancer, Too

A Crucial Breakthrough? Unpacking Novo Nordisk's Bold Price Slash on Wegovy in India

The Murky Underbelly of Wellness: When Local Spas Gamble with Gray Market Drugs

The GLP-1 Gold Rush: Will Trump Rewrite the Rules for Eli Lilly and Novo Nordisk?

The Great GLP-1 Gold Rush: Pfizer Jumps into the Billion-Dollar Battle for Weight Loss Dominance

The Great Weight-Loss Race: Pfizer's Billion-Dollar Gambit to Conquer Obesity

The Great Weight Debate: Unpacking the White House's Bold Move on Obesity Drugs

A Grand Bargain for Health? The Looming Question of Obesity Drugs and Who Pays.

Navigating Today's Health Landscape: From Adult Autism to Viral Challenges and Revolutionary Treatments

Costco Levels Up Healthcare: Introducing SimpleCare for Affordable Weight Loss & Diabetes Solutions

Serena Williams Stuns Fans with Jaw-Dropping Body Transformation in Daring Swimsuit Reveal

Beyond the Buzz: Unpacking the Perils of Cosmetic Weight-Loss Drugs